References

The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma

10.4172/2155-9899.1000202 · 2014 · External reference

Allergic diseases and asthma: a global public health concern and a call to action

10.1186/1939-4551-7-12 · 2014 · External reference

Allergens, sources, particles, and molecules: why do we make IgE responses?

10.1016/j.alit.2015.06.001 · 2015 · External reference

Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys

10.1016/s0140-6736(06)69283-0 · 2006 · External reference

Worldwide time trends for symptoms of rhinitis and conjunctivitis: phase III of the international study of asthma and allergies in childhood

10.1111/j.1399-3038.2007.00601.x · 2008 · External reference

Allergic diseases: a comprehensive review on risk factors, immunological mechanisms, link with COVID-19, potential treatments, and role of allergen bioinformatics

10.3390/ijerph182212105 · 2021 · External reference

Unresolved reference

2014 · External reference

Animal allergens and their presence in the environment

10.3389/fimmu.2014.00076 · 2014 · External reference

Human allergy to cats: a review for veterinarians on prevalence, causes, symptoms and control

10.1177/1098612x211036793 · 2022 · External reference

Respiratory allergens from furred mammals: environmental and occupational exposure

10.3390/vetsci4030038 · 2017 · External reference

Human allergy to cats: a review of the impact on cat ownership and relinquishment

10.1177/1098612x211013016 · 2022 · External reference

Increase in sensitization to common airborne allergens among adults—two population-based studies 15 years apart

10.1186/1710-1492-9-20 · 2013 · External reference

Polysensitisation is associated with more severe symptoms: the reality of patients with allergy

10.1111/cea.14486 · 2024 · External reference

Unresolved reference

2015 · External reference

Unresolved reference

2024 · External reference

An update on molecular cat allergens: fel d 1 and what else? Chapter 1: fel d 1, the major cat allergen

10.1186/s13223-018-0239-8 · 2018 · External reference

Purified natural and recombinant fel d 1 and cat albumin in in vitro diagnostics for cat allergy

10.1016/s0091-6749(99)70017-5 · 1999 · External reference

The effect of cat removal on allergen content in household-dust samples

10.1016/0091-6749(89)90006-7 · 1989 · External reference

Distribution, aerodynamic characteristics, and removal of the major cat allergen fel d 1 in British homes

10.1136/thx.53.1.33 · 1998 · External reference

High prevalence of sensitization to cat allergen among Japanese children with asthma, living without cats

10.1046/j.1365-2222.1999.00472.x · 1999 · External reference

Mechanisms of allergen-specific immunotherapy and allergen tolerance

10.1016/j.alit.2020.08.002 · 2020 · External reference

Subcutaneous immunotherapy with depigmented-polymerized allergen extracts: a systematic review and meta-analysis

10.1186/s13601-019-0268-5 · 2019 · External reference

Biological characterization of glutaraldehyde-modified Parietaria judaica pollen extracts

10.1111/j.1365-2222.2004.01859.x · 2004 · External reference

A review of allergoid immunotherapy: is cat allergy a suitable target?

10.2217/imt.15.121 · 2016 · External reference

In vitro evidence of efficacy and safety of a polymerized cat dander extract for allergen immunotherapy

10.1186/s12865-017-0193-0 · 2017 · External reference

Effectiveness and safety using a depigmented, polymerized extract of cat epithelium: a real-world study [#001451]

External reference

Allergic rhinitis and its impact on asthma (ARIA) guidelines-2016 revision

10.1016/j.jaci.2017.03.050 · 2017 · External reference

Managing adult asthma: the 2019 GINA guidelines

10.3949/ccjm.87a.19136 · 2020 · External reference

Subcutaneous immunotherapy with high-dose cat and dog extracts: a real-life study

10.18176/jiaci.0415 · 2020 · External reference

Does evidence support the use of cat allergen immunotherapy?

10.1097/aci.0000000000000457 · 2018 · External reference

Depigmented, polymerized cat epithelium extract is safe and improves rhinitis and asthma symptoms in cat-allergic patients: a real-world retrospective study

10.1159/000541838 · 2025 · External reference

Health-related quality of life in adult rhinitis: the role of perceived control of disease

10.1016/j.jaci.2004.07.008 · 2004 · External reference

Quality of life in patients with allergic rhinitis

10.1016/s1081-1206(10)62543-4 · 2000 · External reference

Perceived control of asthma and quality of life among adults with asthma

10.1016/s1081-1206(10)61951-5 · 2002 · External reference

Development and validation of a new Spanish instrument to measure health-related quality of life in patients with allergic rhinitis: the ESPRINT questionnaire

10.1111/j.1524-4733.2007.00202.x · 2007 · External reference

Health-related quality of life in allergic rhinitis: comparing the short form ESPRINT-15 and MiniRQLQ questionnaires

10.1111/j.1398-9995.2007.01552.x · 2007 · External reference

Interpretation of quality of life changes

10.1007/bf00435226 · 1993 · External reference

The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control

10.4104/pcrj.2009.00037 · 2009 · External reference

Allergen immunotherapy: a practice parameter third update

10.1016/j.jaci.2010.09.034 · 2011 · External reference

Immunotherapy for cat allergies: a potential strategy to scratch back

10.1177/1559827617701389 · 2017 · External reference

Injection allergen immunotherapy for asthma

10.1002/14651858.cd001186.pub2 · 2010 · External reference

Unresolved reference

External reference

Allergen immunotherapy: past, present and future

10.1038/s41577-022-00786-1 · 2023 · External reference

European Survey on adverse systemic reactions in allergen immunotherapy (EASSI): a real-life clinical assessment

10.1111/all.13066 · 2017 · External reference

Subcutaneous immunotherapy with aeroallergens: safety profile assessment

10.23822/eurannaci.1764-1489.194 · 2022 · External reference

Subcutaneous immunotherapy with a depigmented cat allergoid in patients with cat allergy is safe and results primarily in delayed local reactions [D3.209]

2024 · External reference

The path to personalized medicine

10.1056/nejmp1006304 · 2010 · External reference

Climate change, air pollution, and allergic respiratory diseases: an update

10.1097/aci.0000000000000301 · 2016 · External reference

Climate changes, air pollution and allergic diseases in childhood and adolescence

10.1016/j.jped.2021.10.005 · 2022 · External reference

Allergen immunotherapy (AIT): a prototype of precision medicine

10.1186/s40413-015-0079-7 · 2015 · External reference

Personalized medicine and allergen immunotherapy: the beginning of a new era?

10.1186/s12948-021-00150-z · 2021 · External reference

Hot topics in allergen immunotherapy, 2023: current status and future perspective

10.1111/all.15945 · 2023 · External reference

Mechanisms and biomarkers of successful allergen-specific immunotherapy

10.5415/apallergy.2022.12.e45 · 2022 · External reference

AIT (Allergen immunotherapy): a model for the “precision medicine”

10.1186/s12948-015-0028-6 · 2015 · External reference